-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Haemonetics Corp quarterly/annual Operating Income (Loss) history and growth rate from 2009 to 2023.
- Haemonetics Corp Operating Income (Loss) for the quarter ending September 28, 2024 was $51.7M, a 46.4% increase year-over-year.
- Haemonetics Corp Operating Income (Loss) for the twelve months ending September 28, 2024 was $167M, a 0.07% decline year-over-year.
- Haemonetics Corp annual Operating Income (Loss) for 2023 was $165M, a 5.67% increase from 2022.
- Haemonetics Corp annual Operating Income (Loss) for 2022 was $156M, a 93.2% increase from 2021.
- Haemonetics Corp annual Operating Income (Loss) for 2021 was $80.8M, a 10% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)